Results 151 to 160 of about 112,672 (261)

Current Approaches to Support Patients to Withdraw From Image and Performance Enhancing Drugs

Clinical Endocrinology, EarlyView.
ABSTRACT Image and performance‐enhancing drugs (IPEDs) include agents such as androgens, growth hormone, and erythropoietin, which are used to enhance appearance and physical performance. Androgens, also known as anabolic‐androgenic steroids (AAS), are the most used IPEDs worldwide.
Elizabeth Hyams, Bonnie Grant, Richard Quinton, Channa N. Jayasena   +3 more
wiley   +1 more source

Electrocardiographic Changes After Percutaneous Coronary Intervention for Chronic Total Occlusion. [PDF]

Catheter Cardiovasc Interv
Magoon MJ, Ng P, Thotakura S, Stoyanov N, Kearney KE, Lombardi WL, Chatterjee N, Akoum N, Boyle PM, Nazer B, Azzalini L.   +10 more
europepmc   +1 more source

Assessing Calcified Coronary Lesions to Guide Percutaneous Coronary Intervention: From Angiography to Intracoronary Imaging. [PDF]

Tomography
Kotoulas SC, Triantafyllis AS, Kotoulas AC, Antoniades K, Aqueel I, Pervana AM, Papaioannou N, Peteinaki K, Tsiamis N, Kontogiannis N, Tsinivizov P, Poulimenos LE.   +11 more
europepmc   +1 more source

Machine Learning‐Based Prediction of Dental Caries in 12‐Year‐Old Adolescents: A Nationwide Cross‐Sectional Study in Korea

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Objective We aimed to develop and evaluate machine learning models to support population‐level risk stratification for dental caries in the permanent dentition of 12‐year‐old Korean children and to visualise the relative importance of key predictors.
Gahyun Cho, Hae‐Young Kim, Ki‐Bong Choi, Sunmi Song, Junesun Kim   +4 more
wiley   +1 more source

Mechanical Circulatory Support with iVAC2L During High-Risk Percutaneous Coronary Intervention: A Case Report. [PDF]

J Clin Med
Sibirkstyte G, Barauskas M, Jurenas M, Unikas R, Bastos MB, de Wet Breukelen C.   +5 more
europepmc   +1 more source

Online tool for refining socio‐economic analyses better than postcodes: the example of cardiovascular disease in type 2 diabetes in the FIELD trial

Internal Medicine Journal, EarlyView.
Abstract Background Socio‐economic status (SES) is strongly linked to health outcomes but remains difficult to measure accurately. Conventional approaches based on large geographical units (e.g. postcodes) may obscure SES effects evident at smaller scales.
Andrzej S. Januszewski, Liping Li, Rachel L. O'Connell, James D. Best, R. John Simes, David R. Sullivan, Timothy M. E. Davis, Anthony C. Keech, on behalf of FIELD Trial Investigators   +8 more
wiley   +1 more source

Sex and gender in depression after percutaneous coronary intervention: clinical patterns, mechanistic hypotheses, and care pathways. [PDF]

Front Public Health
Wang J, Yang Z, Hu Y, Liu Z, Wu H, Kong Y, Zhu A.   +6 more
europepmc   +1 more source

Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention

Journal of Diabetes Investigation, EarlyView.
Among patients with type 2 diabetes undergoing percutaneous coronary intervention, thiazolidinedione use was independently associated with a significantly reduced risk of a composite of myocardial infarction, stroke, and all‐cause death, notably without an increased risk of admission for heart failure. ABSTRACT Background Thiazolidinediones (TZD) are a
Jinkwon Kim, Jimin Jeon, Joonsang Yoo, Minyoul Baik, Seok‐Jae Heo, Ji Woong Roh   +5 more
wiley   +1 more source

Remove, Exclude, Ablate: Adding to the Algorithm of Entrapped Equipment Management in Percutaneous Coronary Intervention. [PDF]

JACC Case Rep
Pareek K, Kane JA.
europepmc   +1 more source

Robotic-assisted percutaneous coronary intervention: current evidence and future directions. [PDF]

Front Cardiovasc Med
Bay B, Seiffert M, Brunner FJ.
europepmc   +1 more source